Request availability and a quotation for your required quantity and destination.
| Product | Nitazoxanide 500 mg - Nitazoxanide Tablets |
|---|---|
| Categories | Antibiotics, Tape Worm Infection |
| Pack Size | 60 Tablets, 120 Tablets, 180 Tablets |
| Availability | Confirmed on enquiry |
Product listing is not a recommendation to use this medicine. Prescription and destination requirements apply where relevant.
Existing catalogue category: Antibiotics (category review recommended)
Dosage form: Oral prescription tablets
Strength: 500 mg
Nitazoxanide is an antiprotozoal medicine indicated in the United States for diarrhoea caused by Giardia lamblia or Cryptosporidium parvum in eligible patients. It is not a standard treatment for tapeworm infection.
Its active metabolite interferes with essential energy metabolism in susceptible organisms.
Abdominal pain, nausea, headache and urine discoloration may occur. Seek medical care for severe dehydration, blood in stool, persistent fever or diarrhoea. Effectiveness against Cryptosporidium in immunocompromised people is uncertain.
A qualified clinician should confirm the infection and choose the appropriate treatment schedule. Avoid self-prescribing these medicines for unrelated or unproven uses. Some gastrointestinal infections also require fluids and prevention of reinfection.
It treats specified protozoal diarrhoeal infections in eligible patients.
Yes, Giardia is among its approved indications.
Yes, in immunocompetent people according to reference labeling.
It is not a standard approved treatment for tapeworm infection.
The 500 mg tablet is not appropriate for young children; pediatric dosing uses other formulations.
The labeled tablet regimen is taken with food.
A common labeled course is three days, but clinicians determine the regimen.
Stomach pain, headache and nausea have been reported.
Evidence for Cryptosporidium treatment is uncertain in immunocompromised patients.
Seek care for dehydration, blood in stool, high fever, or persistent symptoms.
Product enquiries are subject to original manufacturer verification, legal import requirements and any applicable prescription. This source-based education is not evidence of independent clinician sign-off.